Search over 3,000 reports

    Diabetic Retinopathy - Market Insights, Epidemiology and Market Forecast-2023

    Diabetic Retinopathy - Market Insights, Epidemiology and Market Forecast-2023
    Date: Nov, 2017
    Type: Pharmaceutical Industry Report
    Pages: 88
    Geography: Global
    Delivery Timeline: 24 Hours
    SKU: DIMI0007
    DelveInsight's Diabetic Retinopathy - Market Insights, Epidemiology and Market Forecast-2023 Report provides an overview of the epidemiology trends of Diabetic Retinopathy in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Diabetic Retinopathy prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Diabetic Retinopathy. The Report provides a comprehensive review of the market trends, drivers, barriers, key company profiles including its business and product developments
    The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by DelveInsight team of industry experts.
    Key Coverage and Benefits:
    • The report will help in developing business strategies by understanding the trends shaping and driving the global Diabetic Retinopathy market.
    • Identifying prevalent patient populations as well as risk factors in the global Diabetic retinopathy market will help to improve product design, pricing, and launch plans.
    • Organize marketing efforts by identifying the best opportunities for Diabetic retinopathy therapeutics in each of the markets covered.
    • To understand the future market competition in the global Diabetic Retinopathy market and Insightful review of the key market drivers and barriers.
    • To understand the regulatory scenario in major markets.
    • The Report also covers the detailed global historical and forecasted Diabetic Retinopathy market covering United States, European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) and Japan from 2013-2023.
    Report Introduction
    Diabetic Retinopathy (DR) Market Overview at a Glance
    Global Market Size of DR in 2015
    Global Market Size of DR in 2023
    Diabetic Retinopathy: Overview
    Stages
    Symptoms
    Types
    Pathophysiology
    Etiology
    Risk Factors
    Disease Burden
    Unmet Needs
    Epidemiology of Diabetic Retinopathy in 7MM (2013-2023)
    United States
    Sex Specific Prevalence of Diabetes Retinopathy in US
    Age- Specific Prevalence of Diabetes Retinopathy in US
    Sub-type Prevalence of Diabetes Retinopathy in US
    EU5
    United Kingdom
    Sex Specific Prevalence of Diabetes Retinopathy in UK
    Age- Specific Prevalence of Diabetes Retinopathy in UK
    Sub-type Prevalence of Diabetes Retinopathy in UK
    France
    Sex Specific Prevalence of Diabetes Retinopathy in France
    Age- Specific Prevalence of Diabetes Retinopathy in France
    Sub-type Prevalence of Diabetes Retinopathy in France
    Italy
    Sex Specific Prevalence of Diabetes Retinopathy in Italy
    Age- Specific Prevalence of Diabetes Retinopathy in Italy
    Sub-type Prevalence of Diabetes Retinopathy in Italy
    Germany
    Sex Specific Prevalence of Diabetes Retinopathy in Germany
    Age- Specific Prevalence of Diabetes Retinopathy in Germany
    Sub-type Prevalence of Diabetes Retinopathy in Germany
    Spain
    Sex Specific Prevalence of Diabetes Retinopathy in Spain
    Age- Specific Prevalence of Diabetes Retinopathy in Spain
    Sub-type Prevalence of Diabetes Retinopathy in Spain
    Japan
    Sex Specific Prevalence of Diabetes Retinopathy in Japan
    Age- Specific Prevalence of Diabetes Retinopathy in Japan
    Sub-type Prevalence of Diabetes Retinopathy in Japan
    Treatment Algorithm
    Marketed Drugs
    EYLEA
    Description
    Regulatory Milestones
    Advantages and Disadvantages
    Product Profile
    Safety & Efficacy
    Side effects of Eylea
    Lucentis
    Description
    Regulatory Milestones
    Advantages and Disadvantages
    Product Profile
    Safety & Efficacy
    Side effects of Lucentis
    Global Diabetic Retinopathy: Country-Wise Market Analysis
    Total Market Size of Diabetic Retinopathy (2013-2023)
    United States
    EU5
    United Kingdom
    Germany
    France
    Italy
    Spain
    Japan
    Market Drivers
    Market Barriers
    Appendix
    Report Methodology
    Consulting Services
    Disclaimer
    About DelveInsight
    Table 1: Prevalent Population of Diabetic Retinopathy in United States (2013-2023)
    Table 2: Sex Specific Prevalence of Diabetes Retinopathy in United States (2013-2023)
    Table 3: Age-Specific Prevalence of Diabetes Retinopathy in United States (2013-2023)
    Table 4: Sub-type Specific Prevalence of Diabetes Retinopathy in United States (2013-2023)
    Table 5: Prevalent Population of Diabetic Retinopathy in United Kingdom (2013-2023)
    Table 6: Sex Specific Prevalence of Diabetes Retinopathy in United Kingdom (2013-2023)
    Table 7: Age-Specific Prevalence of Diabetes Retinopathy in United Kingdom (2013-2023)
    Table 8: Sub-type Specific Prevalence of Diabetes Retinopathy in United Kingdom (2013-2023)
    Table 9: Prevalent Population of Diabetic Retinopathy in France (2013-2023)
    Table 10: Sex Specific Prevalence of Diabetes Retinopathy in France (2013-2023)
    Table 11: Age-Specific Prevalence of Diabetes Retinopathy in France (2013-2023)
    Table 12: Sub-type Specific Prevalence of Diabetes Retinopathy in France (2013-2023)
    Table 13: Prevalent Population of Diabetic Retinopathy in Italy (2013-2023)
    Table 14: Sex Specific Prevalence of Diabetes Retinopathy in Italy (2013-2023)
    Table 15: Age-Specific Prevalence of Diabetes Retinopathy in Italy (2013-2023)
    Table 16: Sub-type Specific Prevalence of Diabetes Retinopathy in Italy (2013-2023)
    Table 17: Prevalent Population of Diabetic Retinopathy in Germany (2013-2023)
    Table 18: Sex Specific Prevalence of Diabetes Retinopathy in Germany (2013-2023)
    Table 19: Age-Specific Prevalence of Diabetes Retinopathy in Germany (2013-2023)
    Table 20: Sub-type Specific Prevalence of Diabetes Retinopathy in Germany (2013-2023)
    Table 21: Prevalent Population of Diabetic Retinopathy in Spain (2013-2023)
    Table 22: Sex Specific Prevalence of Diabetes Retinopathy in Spain (2013-2023)
    Table 23: Age-Specific Prevalence of Diabetes Retinopathy in Spain (2013-2023)
    Table 24: Sub-type Specific Prevalence of Diabetes Retinopathy in Spain (2013-2023)
    Table 25: Prevalent Population of Diabetic Retinopathy in Japan (2013-2023)
    Table 26: Sex Specific Prevalence of Diabetes Retinopathy in Japan (2013-2023)
    Table 27: Age-Specific Prevalence of Diabetes Retinopathy in Japan (2013-2023)
    Table 28: Sub-type Specific Prevalence of Diabetes Retinopathy in Japan (2013-2023)
    Table 29: Total Market size of Diabetic Retinopathy in USD Billion (2013-2023)
    Table 30: United States Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
    Table 31: United Kingdom Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
    Table 32: Germany Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
    Table 33: France Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
    Table 34: Italy Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
    Table 35: Spain Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
    Table 36: Japan Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
    Figure 1: Risk Factors of Diabetic Retinopathy
    Figure 2: Prevalent Population of Diabetic Retinopathy in United States (2013-2023)
    Figure 3: Sex Specific Prevalence of Diabetes Retinopathy in United States (2013-2023)
    Figure 4: Age-Specific Prevalence of Diabetes Retinopathy in United States (2013-2023)
    Figure 5: Sub-type Specific Prevalence of Diabetes Retinopathy in United States (2013-2023)
    Figure 6: Prevalent Population of Diabetes Retinopathy in United Kingdom (2013-2023)
    Figure 7: Sex Specific Prevalence of Diabetes Retinopathy in United Kingdom (2013-2023)
    Figure 8: Age- Specific Prevalence of Diabetes Retinopathy in United Kingdom (2013-2023)
    Figure 9: Sub-type Specific Prevalence of Diabetes Retinopathy in United Kingdom (2013-2023)
    Figure 10: Prevalent Population of Diabetic Retinopathy in France (2013-2023)
    Figure 11: Sex Specific Prevalence of Diabetes Retinopathy in France (2013-2023)
    Figure 12: Age- Specific Prevalence of Diabetes Retinopathy in France (2013-2023)
    Figure 13: Sub-type Specific Prevalence of Diabetes Retinopathy in France (2013-2023)
    Figure 14: Prevalent Population of Diabetic Retinopathy in Italy (2013-2023)
    Figure 15: Sex Specific Prevalence of Diabetes Retinopathy in Italy (2013-2023)
    Figure 16: Age-Specific Prevalence of Diabetes Retinopathy in Italy (2013-2023)
    Figure 17: Sub-type Specific Prevalence of Diabetes Retinopathy in Italy (2013-2023)
    Figure 18: Prevalent Population of Diabetic Retinopathy in Germany (2013-2023)
    Figure 19: Sex Specific Prevalence of Diabetes Retinopathy in Germany (2013-2023)
    Figure 20: Age- Specific Prevalence of Diabetes Retinopathy in Germany (2013-2023)
    Figure 21: Sub-type Specific Prevalence of Diabetes Retinopathy in Germany (2013-2023)
    Figure 22: Prevalent Population of Diabetic Retinopathy Spain (2013-2023)
    Figure 23: Sex Specific Prevalence of Diabetes Retinopathy in Spain (2013-2023)
    Figure 24: Age- Specific Prevalence of Diabetes Retinopathy in Spain (2013-2023)
    Figure 25: Sub-type Specific Prevalence of Diabetes Retinopathy in Spain (2013-2023)
    Figure 26: Prevalent Population of Diabetic Retinopathy in Japan (2013-2023)
    Figure 27: Sex Specific Prevalence of Diabetes Retinopathy in Japan (2013-2023)
    Figure 28: Age-Specific Prevalence of Diabetes Retinopathy in Japan (2013-2023)
    Figure 29: Sub-type Specific Prevalence of Diabetes Retinopathy in Japan (2013-2023)
    Figure 30: Total Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
    Figure 31: United States Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
    Figure 32: United Kingdom Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
    Figure 33: Germany Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
    Figure 34: France Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
    Figure 35: Italy Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
    Figure 36: Spain Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
    Figure 37: Japan Market Size of Diabetic Retinopathy in USD, Billion (2013-2023)
    Diabetic Retinopathy Market (7MM)

    Diabetic Retinopathy Market forecasting

    Diabetic Retinopathy Sales forecasting

    Diabetic Retinopathy Market segments

    Diabetic Retinopathy Epidemiology

    Diabetic Retinopathy Pipeline products and technologies

    Diabetic Retinopathy Competitive landscape

    Diabetic Retinopathy SWOT analysis

    Diabetic Retinopathy Market Driver's and barriers

    Diabetic Retinopathy Key Companies and Funding

    • Single User License
      (20% Off)
      $4,950.00
      $3960
    • Site License
      (30% Off)
      $9,900.00
      $6930
    • Global License
      (40% Off)
      $14,850.00
      $8910

    Contact Us

    Phone
    +91-11-45689769, +91 9650213330

    Email
    info@delveinsight.com

    Address
    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap